Review ArticleSystematic Review
Open Access

The association between the CC chemokine ligand 5 -28C>G gene polymorphism and tuberculosis susceptibility

Hongfang Lu, Jingang Wang, Baoan Gao, Shixiong Chen, Guangming Xiang, Shaojuan Yang, Yuan Gong and Li Guan
Saudi Medical Journal December 2015, 36 (12) 1400-1407; DOI: https://doi.org/10.15537/smj.2015.12.12264

References

  1. ↵
    1. Jo EK,
    2. Park JK,
    3. Dockrell HM
    (2003) Dynamics of cytokine generation in patients with active pulmonay tuberculosis. Curr Opin Infect Dis 16:205–210.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. World Health Organization
    (2010) Global tuberculosis report 2015 (World Health Organization, Geneva (CH)) Available from URL:http://www.who.int/tb/publications/global_report/en/.
  3. ↵
    1. Qu HQ,
    2. Fisher-Hoch SP,
    3. McCormick JB
    (2011) Knowledge gaining by human genetic studies on tuberculosis Susceptibility. J Hum Genet 56:177–182.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Zhang Y,
    2. Jiang T,
    3. Yang X,
    4. Xue Y,
    5. Wang C,
    6. Liu J,
    7. et al.
    (2013) Toll-like receptor -1, -2, and -6 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis. PLoS One 8:e63357.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Wang C,
    2. Chen ZL,
    3. Pan ZF,
    4. Wei LL,
    5. Xu DD,
    6. Jiang TT,
    7. et al.
    (2013) NOD2 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis. Int J Biol Sci 10:103–108.
    OpenUrl
  6. ↵
    1. Liu G,
    2. Li G,
    3. Xu Y,
    4. Song N,
    5. Shen S,
    6. Jiang D,
    7. et al.
    (2014) Association between IL12B polymorphisms and tuberculosis risk: A meta-analysis. Infect Genet Evol 21:401–407.
    OpenUrl
  7. ↵
    1. Wang C,
    2. Jiang T,
    3. Wei L,
    4. Li F,
    5. Sun X,
    6. Fan D,
    7. et al.
    (2012) Association of CTLA4 Gene Polymorphisms with Susceptibility and Pathology Correlation to Pulmonary Tuberculosis in Southern Han Chinese. Int J Biol Sci 8:945–952.
    OpenUrlPubMed
  8. ↵
    1. Taub DD,
    2. Turcovski-Corrales SM,
    3. Key ML,
    4. Longo DL,
    5. Murphy WJ
    (1996) Chemokines and T-lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 156:2095–2103.
    OpenUrlAbstract
  9. ↵
    1. Mendez-Samperio P
    (2008) Expression and regulation of chemokines in mycobacterial infection. J Infect 57:374–84.
    OpenUrl
  10. ↵
    1. Nickel RG,
    2. Casolaro V,
    3. Wahn U,
    4. Beyer K,
    5. Barnes KC,
    6. Plunkett BS,
    7. et al.
    (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164:1612–1616.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Liu H,
    2. Chao D,
    3. Nakayama EE,
    4. Taguchi H,
    5. Goto M,
    6. Xin X,
    7. et al.
    (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 96:4581–4585.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Zhernakova A,
    2. Alizadeh BZ,
    3. Eerligh P,
    4. Hanifi-Moghaddam P,
    5. Schloot NC,
    6. Diosdado B,
    7. et al.
    (2006) Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes Immun 7:544–549.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Cochrane Handbook for Systematic Reviews of Interventions,
    2. Higgins JPT,
    3. Green S
    , eds (2008) Cochrane Book Series (John Wiley & Sons, Chichester (UK)), pp 11–78.
  14. ↵
    1. Liberati A,
    2. Altman DG,
    3. Tetzlaff J,
    4. Mulrow C,
    5. Gotzsche PC,
    6. Ioannidis JP,
    7. et al.
    (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Moher D,
    2. Liberati A,
    3. Tetzlaff J,
    4. Altman DG,
    5. The PRISMA Group
    (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6:e1000097.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Mantel N,
    2. Haenszel W
    (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748.
    OpenUrlPubMedWeb of Science
  17. ↵
    1. Lau J,
    2. Ioannidis JP,
    3. Schmid CH
    (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820–826.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Egger M,
    2. Davey Smith G,
    3. Schneider M,
    4. Minder C
    (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Ben-Selma W,
    2. Harizi H,
    3. Bougmiza I,
    4. Ben Kahla I,
    5. Letaief M,
    6. Boukadida J
    (2011) Polymorphisms in the RANTES gene increase susceptibility to active tuberculosis in Tunisia. DNA Cell Biol 30:789–800.
    OpenUrlCrossRefPubMed
    1. Chu SF,
    2. Tam CM,
    3. Wong HS,
    4. Kam KM,
    5. Lau YL,
    6. Chiang AK
    (2007) Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun 8:475–479.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Mhmoud N,
    2. Fahal A,
    3. van de Sande WJ
    (2013) Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese population. Trop Med Int Health 18:1119–1127.
    OpenUrl
    1. Mishra G,
    2. Poojary SS,
    3. Raj P,
    4. Tiwari PK
    (2012) Genetic polymorphisms of CCL2, CCL5, CCR2 and CCR5 genes in Sahariya tribe of North Central India: an association study with pulmonary tuberculosis. Infect Genet Evol 12:1120–1127.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Sánchez-Castañón M,
    2. Baquero IC,
    3. Sánchez-Velasco P,
    4. et al.
    (2009) Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain. Int J Tuberc Lung Dis 13:480–485.
    OpenUrlPubMed
  24. ↵
    1. Selvaraj P,
    2. Alagarasu K,
    3. Singh B,
    4. Afsal K
    (2011) CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India. Int J Immunogenet 38:397–402.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Sui RZ
    (2011) Associations between CCL5 Gene polymorphisms and genetic susceptibility to tuberculosis in Ningxia population [dissertation] (Ningxia Medical University, Yinchuan (China)).
  26. ↵
    1. Zhang JJ
    (2011) Study of relationship of CCL5 gene polymorphism with pulmonary tuberculosis in the Henan Han population [D] (Zhengzhou University, Henan (China)).
  27. ↵
    1. Mahasirimongkol S,
    2. Yanai H,
    3. Mushiroda T,
    4. Promphittayarat W,
    5. Wattanapokayakit S,
    6. Phromjai J,
    7. et al.
    (2012) Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis. J Hum Genet 57:363–367.
    OpenUrlCrossRefPubMed
    1. Thye T,
    2. Vannberg FO,
    3. Wong SH,
    4. Owusu-Dabo E,
    5. Osei I,
    6. Gyapong J,
    7. et al.
    (2010) Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 42:739–741.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Zhang X,
    2. Jiang F,
    3. Wei L,
    4. Li F,
    5. Liu J,
    6. Wang C,
    7. et al.
    (2012) Polymorphic allele of human MRC1 confers protection against tuberculosis in a Chinese population. Int J Biol Sci 8:375–382.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Chensue SW,
    2. Warmington KS,
    3. Allenspach EJ,
    4. Lu B,
    5. Gerard C,
    6. Kunkel SL,
    7. et al.
    (1999) Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 163:165–173.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Sadek MI,
    2. Sada E,
    3. Toossi Z,
    4. Schwander SK,
    5. Rich E A
    (1998) Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 19:513–521.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Areeshi MY,
    2. Mandal Raju K,
    3. Panda Aditya K,
    4. Shafiul H
    (2013) A meta-analysis of the association between the CC chemokine ligand 5 (CCL5) -403 G>A gene polymorphism and tuberculosis susceptibility. PLoS One 8:e72139.
    OpenUrl
  33. ↵
    1. Alqumber MA,
    2. Mandal RK,
    3. Haque S,
    4. Panda AK,
    5. Akhter N,
    6. Ali A
    (2013) A genetic association study of CCL5 -28 C>G(rs2280788) polymorphism with risk of tuberculosis: A meta-analysis. PLoS One 8:e83422.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section